nejm.org This article is for educational purposes only and does not constitute medical advice
Oxygen is a primary driver of oxidation, one of the major degradation pathways for peptides
Is tirzepatide used to treat hypertension
By delivering comparable weight loss results to injectable semaglutide in clinical trials, without the need for injections, it provides GLP-1 therapy as an option for patients who prefer oral medications or who have avoided injectables
A laboratory may need to compare individual products, larger packs, product naming, delivery expectations and internal approval requirements before placing an order
A plausible scenario, then, looks like this: Phase 3 primary completion in late 2025, NDA submission in the second half of 2025, FDA filing acceptance and review initiation in early 2026, and a PDUFA (Prescription Drug User Fee Act) action date likely in mid to late 2026